DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $38,000 | +216.7% | 9,718 | +303.6% | 0.00% | – |
| Q3 2019 | $12,000 | -58.6% | 2,408 | -49.6% | 0.00% | – |
| Q2 2019 | $29,000 | +222.2% | 4,782 | +184.8% | 0.00% | – |
| Q1 2019 | $9,000 | -80.9% | 1,679 | -50.5% | 0.00% | – |
| Q4 2018 | $47,000 | -46.6% | 3,393 | -25.1% | 0.00% | – |
| Q3 2018 | $88,000 | +33.3% | 4,532 | +77.1% | 0.00% | – |
| Q2 2018 | $66,000 | +230.0% | 2,559 | +167.4% | 0.00% | – |
| Q1 2018 | $20,000 | -96.9% | 957 | -97.0% | 0.00% | – |
| Q4 2017 | $636,000 | -4.1% | 31,707 | -1.0% | 0.00% | – |
| Q3 2017 | $663,000 | +27.3% | 32,018 | -9.2% | 0.00% | – |
| Q2 2017 | $521,000 | +15.5% | 35,266 | +25.0% | 0.00% | – |
| Q1 2017 | $451,000 | +146.4% | 28,210 | +93.6% | 0.00% | – |
| Q4 2016 | $183,000 | +2514.3% | 14,570 | +5895.9% | 0.00% | – |
| Q3 2016 | $7,000 | -99.3% | 243 | -99.1% | 0.00% | -100.0% |
| Q2 2016 | $969,000 | +19280.0% | 27,698 | +13749.0% | 0.00% | – |
| Q1 2016 | $5,000 | -97.5% | 200 | -96.6% | 0.00% | – |
| Q4 2015 | $203,000 | +351.1% | 5,914 | +281.1% | 0.00% | – |
| Q3 2015 | $45,000 | -37.5% | 1,552 | -4.0% | 0.00% | – |
| Q2 2015 | $72,000 | +323.5% | 1,617 | +228.0% | 0.00% | – |
| Q1 2015 | $17,000 | -96.2% | 493 | -97.0% | 0.00% | – |
| Q4 2014 | $447,000 | – | 16,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|